Towards robust immune responses after heterologous COVID-19 vaccination and its application perspectives

Saved in:
Bibliographic Details
Main Authors: Lin Yong, Huang Ailong
Format: Article
Language:English
Published: Science Press 2022-03-01
Series:National Science Open
Online Access:https://www.sciengine.com/doi/10.1360/nso/20220008
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850236183710269440
author Lin Yong
Huang Ailong
author_facet Lin Yong
Huang Ailong
author_sort Lin Yong
collection DOAJ
format Article
id doaj-art-bbd5cab40b5f41428b99f84eb6c771e7
institution OA Journals
issn 2097-1168
language English
publishDate 2022-03-01
publisher Science Press
record_format Article
series National Science Open
spelling doaj-art-bbd5cab40b5f41428b99f84eb6c771e72025-08-20T02:02:01ZengScience PressNational Science Open2097-11682022-03-01110.1360/nso/20220008eb33e642Towards robust immune responses after heterologous COVID-19 vaccination and its application perspectivesLin Yong0Huang Ailong1[][]https://www.sciengine.com/doi/10.1360/nso/20220008
spellingShingle Lin Yong
Huang Ailong
Towards robust immune responses after heterologous COVID-19 vaccination and its application perspectives
National Science Open
title Towards robust immune responses after heterologous COVID-19 vaccination and its application perspectives
title_full Towards robust immune responses after heterologous COVID-19 vaccination and its application perspectives
title_fullStr Towards robust immune responses after heterologous COVID-19 vaccination and its application perspectives
title_full_unstemmed Towards robust immune responses after heterologous COVID-19 vaccination and its application perspectives
title_short Towards robust immune responses after heterologous COVID-19 vaccination and its application perspectives
title_sort towards robust immune responses after heterologous covid 19 vaccination and its application perspectives
url https://www.sciengine.com/doi/10.1360/nso/20220008
work_keys_str_mv AT linyong towardsrobustimmuneresponsesafterheterologouscovid19vaccinationanditsapplicationperspectives
AT huangailong towardsrobustimmuneresponsesafterheterologouscovid19vaccinationanditsapplicationperspectives